{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T04:04:13Z","timestamp":1745640253101,"version":"3.40.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00277-025-06202-7","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T02:51:02Z","timestamp":1737600662000},"page":"1867-1876","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation and tyrosine kinase inhibitors: development and validation of a clinical prediction model based on cytogenetics, IKZF1 deletions and minimal residual disease"],"prefix":"10.1007","volume":"104","author":[{"given":"Jing","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanmin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yishan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huarui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiyan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingsong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoqing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"key":"6202_CR1","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1056\/NEJMra2113347","volume":"386","author":"R Fo\u00e0","year":"2022","unstructured":"Fo\u00e0 R, Chiaretti S (2022) Philadelphia chromosome-positive acute lymphoblastic leukemia. N Engl J Med 386:2399\u20132411","journal-title":"N Engl J Med"},{"key":"6202_CR2","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1001\/jamaoncol.2018.1915","volume":"4","author":"E Jabbour","year":"2018","unstructured":"Jabbour E, Pui C-H, Kantarjian H (2018) Progress and innovations in the management of adult acute lymphoblastic leukemia. JAMA Oncol 4:1413\u20131420","journal-title":"JAMA Oncol"},{"key":"6202_CR3","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.3324\/haematol.2012.080432","volume":"98","author":"S Chiaretti","year":"2013","unstructured":"Chiaretti S, Vitale A, Cazzaniga G et al (2013) Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts. Haematologica 98:1702\u20131710","journal-title":"Haematologica"},{"key":"6202_CR4","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.bbmt.2017.12.777","volume":"24","author":"J Wang","year":"2018","unstructured":"Wang J, Jiang Q, Xu LP et al (2018) Allogeneic stem cell transplantation versus tyrosine kinase inhibitors combined with chemotherapy in patients with Philadelphia chromosome-positive Acute Lymphoblastic Leukemia. Biol Blood Marrow Transpl 24:741\u2013750","journal-title":"Biol Blood Marrow Transpl"},{"key":"6202_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/MEG.0000000000002678","volume":"36","author":"W Zhang","year":"2014","unstructured":"Zhang W, Chen Z, Sa B (2014) Construction and validation of the predictive model for gallbladder cancer liver metastasis patients: a SEER-based study. Eur J Gastroenterol Hepatol 36:129\u2013134","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"6202_CR6","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1186\/s12885-023-10990-4","volume":"23","author":"L Luo","year":"2023","unstructured":"Luo L, Tan Y, Zhao S et al (2023) The potential of high-order features of routine blood test in predicting the prognosis of non-small cell lung cancer. BMC Cancer 23:496","journal-title":"BMC Cancer"},{"key":"6202_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.1021587","volume":"10","author":"L Zhang","year":"2022","unstructured":"Zhang L, Chen S, Wang W et al (2022) A prognostic model for patients with primary extramedullary multiple myeloma. Front Cell Dev Biol 10:1021587","journal-title":"Front Cell Dev Biol"},{"key":"6202_CR8","doi-asserted-by":"publisher","first-page":"e030733","DOI":"10.1136\/bmjopen-2019-030733","volume":"9","author":"H Xing","year":"2019","unstructured":"Xing H, Zhou W, Fan Y et al (2019) Development and validation of a postoperative delirium prediction model for patients admitted to an intensive care unit in China: a prospective study. BMJ Open 9:e030733","journal-title":"BMJ Open"},{"key":"6202_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/ijc.2910180105","volume":"18","author":"F Mitelman","year":"1976","unstructured":"Mitelman F, Levan G, Nilsson PG et al (1976) Non-random karyotypic evolution in chronic myeloid leukemia. Int J Cancer 18:24\u201330","journal-title":"Int J Cancer"},{"key":"6202_CR10","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000046636","volume":"107","author":"B Johansson","year":"2022","unstructured":"Johansson B, Fioretos T, Mitelman F (2022) Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol 107:76\u201394","journal-title":"Acta Haematol"},{"key":"6202_CR11","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1001\/jamaoncol.2022.2398","volume":"8","author":"E Jabbour","year":"2022","unstructured":"Jabbour E, Haddad FG, Short NJ et al (2022) Treatment of adults with Philadelphia chromosome-positive Acute Lymphoblastic leukemia-from intensive chemotherapy combinations to Chemotherapywa-Free regimens: a review. JAMA Oncol 8:1340\u20131348","journal-title":"JAMA Oncol"},{"key":"6202_CR12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.clml.2023.01.002","volume":"23","author":"M Shahzad","year":"2023","unstructured":"Shahzad M, Hussain A, Tariq E et al (2023) Outcomes of tyrosine kinase inhibitors maintenance therapy with or without allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome positive acute lymphoblastic leukemia in first complete remission: a systematic review and meta-analysis. Clin Lymphoma Myeloma Leuk 23:178\u2013187","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"6202_CR13","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1007\/s00277-024-05871-0","volume":"103","author":"J Zheng","year":"2024","unstructured":"Zheng J, Zhao Y, Luo Y et al (2024) Impact of additional cytogenetic aberrations at diagnosis on prognosis of adults patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic cell transplantation: a retrospective analysis. Ann Hematol 103:2983\u20132991","journal-title":"Ann Hematol"},{"key":"6202_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1182\/blood-2020-139826","volume":"136","author":"M Bonifacio","year":"2020","unstructured":"Bonifacio M, Elena C, Mariella DA et al (2020) Do not miss karyotyping at chronic myeloid leukemia diagnosis: an Italian campus CML Study on the role of complex variant translocations. Blood 136:43\u201344","journal-title":"Blood"},{"key":"6202_CR15","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1038\/s41375-020-0826-9","volume":"34","author":"R Hehlmann","year":"2020","unstructured":"Hehlmann R, Voskanyan A, Lauseker M et al (2020) High-risk additional chromosomal abnormalities at low blast counts herald death by CML. Leukemia 34:2074\u20132086","journal-title":"Leukemia"},{"key":"6202_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/cncr.30376","volume":"123","author":"GC Issa","year":"2017","unstructured":"Issa GC, Kantarjian HM, Yin CC et al (2017) Prognostic impact of pretreatment cytogenetics in adult Philadelphia chromosome negative acute lymphoblastic leukemia in the era of minimal residual disease. Cancer 123:459\u2013467","journal-title":"Cancer"},{"key":"6202_CR17","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1182\/blood-2006-10-051912","volume":"109","author":"AV Moorman","year":"2007","unstructured":"Moorman AV, Harrison CJ, Buck GA et al (2007) Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII\/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood 109:3189\u20133197","journal-title":"Blood"},{"key":"6202_CR18","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1007\/s00277-021-04587-9","volume":"100","author":"R Hara","year":"2021","unstructured":"Hara R, Onizuka M, Kikkawa E et al (2021) Association between measurable residual disease kinetics and outcomes of Philadelphia chromosome-positive acute lymphoblastic leukemia. Ann Hematol 100:2479\u20132486","journal-title":"Ann Hematol"},{"key":"6202_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20215362","volume":"20","author":"A Czyz","year":"2019","unstructured":"Czyz A, Nagler A (2019) The role of measurable residual disease (MRD) in hematopoietic stem cell transplantation for hematological malignancies focusing on Acute Leukemia. Int J Mol Sci 20:5362","journal-title":"Int J Mol Sci"},{"key":"6202_CR20","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1007\/s12185-021-03094-x","volume":"113","author":"Y Akahoshi","year":"2021","unstructured":"Akahoshi Y, Arai Y, Nishiwaki S et al (2021) Minimal residual disease (MRD) positivity at allogeneic hematopoietic cell transplantation, not the quantity of MRD, is a risk factor for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia. Int J Hematol 113:832\u2013839","journal-title":"Int J Hematol"},{"key":"6202_CR21","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.4103\/0366-6999.161365","volume":"128","author":"Z Ding","year":"2015","unstructured":"Ding Z, Han MZ, Chen SL et al (2015) Outcomes of adults with Acute Lymphoblastic Leukemia after autologous hematopoietic stem cell transplantation and the significance of Pretransplantation minimal residual disease: analysis from a single Center of China. Chin Med J (Engl) 128:2065\u20132071","journal-title":"Chin Med J (Engl)"},{"key":"6202_CR22","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1200\/JCO.2016.69.0073","volume":"35","author":"KG Roberts","year":"2017","unstructured":"Roberts KG, Gu Z, Payne-Turner D et al (2017) High frequency and poor outcome of Philadelphia chromosome-like acute lymphoblastic leukemia in adults. J Clin Oncol 35:394\u2013401","journal-title":"J Clin Oncol"},{"key":"6202_CR23","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1182\/blood.2023020794","volume":"143","author":"N G\u00f6kbuget","year":"2024","unstructured":"G\u00f6kbuget N, Boissel N, Chiaretti S et al (2024) Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel. Blood 143:1891\u20131902","journal-title":"Blood"},{"key":"6202_CR24","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3324\/haematol.2017.185603","volume":"103","author":"R Marke","year":"2018","unstructured":"Marke R, van Leeuwen FN, Scheijen B (2018) The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia. Haematologica 103:565\u2013574","journal-title":"Haematologica"},{"key":"6202_CR25","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.3109\/10428194.2016.1144881","volume":"57","author":"R DeBoer","year":"2016","unstructured":"DeBoer R, Koval G, Mulkey F et al (2016) Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665. Leuk Lymphoma 57:2298\u20132306","journal-title":"Leuk Lymphoma"},{"key":"6202_CR26","first-page":"301","volume":"58","author":"SH Tang","year":"2019","unstructured":"Tang SH, Lu Y, Zhang PS et al (2019) Ikaros family zinc finger 1 mutation is a poor prognosic factor for adult Philadelphia chromosome positive acute lymphoblastic leukemia. Chin J Intern Med 58:301\u2013306","journal-title":"Chin J Intern Med"},{"key":"6202_CR27","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/bmt.2014.281","volume":"50","author":"M Kim","year":"2015","unstructured":"Kim M, Park J, Kim DW et al (2015) Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALL. Bone Marrow Transpl 50:354\u2013362","journal-title":"Bone Marrow Transpl"},{"key":"6202_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12010089","volume":"12","author":"J Paolino","year":"2024","unstructured":"Paolino J, Tsai HK, Harris MH et al (2024) IKZF1 alterations and therapeutic targeting in B-Cell Acute Lymphoblastic Leukemia. Biomedicines 12:89","journal-title":"Biomedicines"},{"key":"6202_CR29","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3324\/haematol.2018.196055","volume":"104","author":"AL Fedullo","year":"2019","unstructured":"Fedullo AL, Messina M, Elia L, Piciocchi A et al (2019) Prognostic implications of additional genomic lesions in adult Philadelphia chromosome-positive acute lymphoblastic leukemia. Haematologica 104:312\u2013318","journal-title":"Haematologica"},{"key":"6202_CR30","doi-asserted-by":"publisher","first-page":"204062072311512","DOI":"10.1177\/20406207231151294","volume":"14","author":"FG Haddad","year":"2023","unstructured":"Haddad FG, Sawyers J, Short NJ (2023) Treatment de-escalation in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia: the emerging role of chemotherapy-free regimens. Ther Adv Hematol 14:20406207231151294","journal-title":"Ther Adv Hematol"},{"key":"6202_CR31","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1200\/JCO.23.01075","volume":"42","author":"R Fo\u00e0","year":"2024","unstructured":"Fo\u00e0 R, Bassan R, Elia L et al (2024) Long-term results of the dasatinib-blinatumomab protocol for adult Philadelphia-positive ALL. J Clin Oncol 42:881\u2013885","journal-title":"J Clin Oncol"},{"key":"6202_CR32","doi-asserted-by":"publisher","first-page":"2335856","DOI":"10.1080\/16078454.2024.2335856","volume":"29","author":"ZY Xiong","year":"2024","unstructured":"Xiong ZY, Shen YJ, Zhang SZ et al (2024) A review of immunotargeted therapy for Philadelphia chromosome positive acute lymphoblastic leukaemia: making progress in chemotherapy-free regimens. Hematology 29:2335856","journal-title":"Hematology"},{"key":"6202_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/17474086.2023.2298732","volume":"17","author":"Y Zhai","year":"2024","unstructured":"Zhai Y, Hong J, Wang J et al (2024) Comparison of blinatumomab and CAR T-cell therapy in relapsed\/refractory acute lymphoblastic leukemia: a systematic review and meta-analysis. Expert Rev Hematol 17:67\u201376","journal-title":"Expert Rev Hematol"},{"key":"6202_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41409-020-0982-6","volume":"56","author":"B Gu","year":"2021","unstructured":"Gu B, Shi BY, Zhang X et al (2021) Allogeneic haematopoietic stem cell transplantation improves outcome of adults with relapsed\/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia entering remission following CD19 chimeric antigen receptor T cells. Bone Marrow Transpl 56:91\u2013100","journal-title":"Bone Marrow Transpl"},{"key":"6202_CR35","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1182\/blood-2017-07-796862","volume":"131","author":"H Pfeifer","year":"2018","unstructured":"Pfeifer H, Raum K, Markovic S et al (2018) Genomic CDKN2A\/2B deletions in adult Ph\u2009+\u2009ALL are adverse despite allogeneic stem cell transplantation. Blood 131:1464\u20131475","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06202-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06202-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06202-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T10:09:59Z","timestamp":1745575799000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06202-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["6202"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06202-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2025,1,23]]},"assertion":[{"value":"30 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}